The objective of this study is to describe contemporary, real-world patterns of patient characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in patients with newly diagnosed multiple myeloma and patients with relapsed/refractory multiple myeloma.

Clinical Program: Malignant Hematology Program
Primary Sponsor: Millennium Pharmaceuticals, Inc.
Contact Info: 202-741-3379